SLAMF6P1: A Drug Target / Disease Biomarker (G100862852)

Target Name: SLAMF6P1

NCBI ID: G100862852

SLAMF6P1

Other Name(s): SLAM family member 6 pseudogene 1

SLAMF6P1: A Drug Target / Disease Biomarker

SLAMF6P1, also known as SLAMF6P1L, is a protein that is expressed in various tissues throughout the body, including the brain, muscle, and bones. It is a member of the SLAM family of proteins, which are involved in the process of cell-cell adhesion.

SLAMF6P1 is known for its role in the development and maintenance of tissues, particularly the nervous system. It has been shown to play a key role in the formation of neural stem cells, which are responsible for the development and maintenance of the nervous system throughout life.

In addition to its role in neural development, SLAMF6P1 is also involved in the regulation of pain and inflammation. It has been shown to play a key role in the production of pain signals, as well as in the regulation of inflammation.

Due to its involvement in these processes, SLAMF6P1 has potential as a drug target or biomarker for a variety of diseases. For example, it has been shown to be a potential therapeutic target for the treatment of neurodegenerative diseases, such as Alzheimer's disease and Parkinson's disease.

SLAMF6P1 has also been shown to be a potential biomarker for a variety of inflammatory diseases, including rheumatoid arthritis and multiple sclerosis.

In conclusion, SLAMF6P1 is a protein that has important roles in the development and maintenance of tissues, including the nervous system, and in the regulation of pain and inflammation. Its potential as a drug target or biomarker makes it an attractive target for research into a variety of diseases. Further studies are needed to fully understand its role in these processes and its potential as a therapeutic agent.

Protein Name: SLAM Family Member 6 Pseudogene 1

The "SLAMF6P1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SLAMF6P1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets